HEPHAISTOS-Pharma

Orsay, France

Hephaistos Pharma is a biotech company developing oncology treatments.

$4.9M raised

Jan 2024

Seed

Biotechnology Oncology

Top Investors

BpifranceElaiaFrance 2030EASMEEIC Accelerator

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about HEPHAISTOS-Pharma

How much funding has HEPHAISTOS-Pharma raised?

HEPHAISTOS-Pharma has raised $4.9M in total funding. The most recent round was Seed. The last funding was announced in January 2024.

Who are HEPHAISTOS-Pharma's investors?

HEPHAISTOS-Pharma's investors include Bpifrance, Elaia, France 2030, EASME, EIC Accelerator.

Where is HEPHAISTOS-Pharma headquartered?

HEPHAISTOS-Pharma is headquartered in Orsay, France.

What does HEPHAISTOS-Pharma do?

Hephaistos Pharma is a biotech company developing oncology treatments.

What stage is HEPHAISTOS-Pharma at?

HEPHAISTOS-Pharma is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 23, 2024.

MLA

"HEPHAISTOS-Pharma — Funding & Investors." VCBacked, January 23, 2024, https://www.vcbacked.co/company/hephaistos-pharma. Accessed June 4, 2026.

APA

VCBacked. (2024). HEPHAISTOS-Pharma — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/hephaistos-pharma

Wikipedia (cite web)

{{cite web |title=HEPHAISTOS-Pharma — Funding & Investors |url=https://www.vcbacked.co/company/hephaistos-pharma |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 23, 2024.

Similar Companies in Biotechnology